MedTrace Logo

PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis

NCT01594411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 251

Last updated 2019-01-31

Study results available
· View outcomes & findings →

Summary

This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.

Conditions

Interventions

DIAGNOSTIC_TEST

Corus CAD

Age/Sex/Gene Expression Score (ASGES)

Sponsors & Collaborators

  • CardioDx

    lead INDUSTRY

Principal Investigators

  • May Yau, MS · CardioDx

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-01-31
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594411 on ClinicalTrials.gov